DBV Technologies | DBVT - Passivo Circulante





Passivo Circulante Alterar Data
Acadia Pharmaceuticals USD 305.52M 28.41M 2026-03
Alnylam Pharmaceuticals USD 1.51B 163.04M 2026-06
Amarin USD 164.2M 15.45M 2026-06
BioCryst Pharmaceuticals USD 195.39M 675K 2026-03
BioMarin Pharmaceutical USD 793.15M 34.12M 2026-03
DBV Technologies USD 54.3M 2.5M 2026-06
Galectin Therapeutics USD 14.62M 1.98M 2024-06
Halozyme Therapeutics USD 363.21M 186.12M 2026-03
Incyte USD 1.31B 177.55M 2026-06
Insmed USD 361.01M 107.87M 2026-03
Ionis Pharmaceuticals USD 315.64M 401.36M 2026-06
Neurocrine Biosciences USD 874.5M 42.8M 2026-06
PTC Therapeutics USD 771.07M 152.54M 2026-06
Sarepta Therapeutics USD 499.16M 596.13M 2026-03
Ultragenyx Pharmaceutical USD 325M 59M 2026-03
United Therapeutics USD 599.1M 38.5M 2026-03